Jump to content

When Using A Treatment Policy Estimand: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

13 August 2026

  • curprev 21:5121:51, 13 August 2026 PrincessSchindle talk contribs 6,400 bytes +6,400 Created page with "<br>Bagsværd, Denmark, 4 June 2021 - Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Wegovy™ (the brand name for once-weekly semaglutide 2.4 mg injection in the US) for chronic weight management. Wegovy™ is indicated as an adjunct to diet and exercise for chronic weight management in adults with obesity (initial BMI≥30 kg/m2) or overweight (initial BMI≥27 kg/m2) with at least one weight-related comorbidity. Wegovy™ is t..."
Retrieved from "https://www.mundaneadventures.com/index.php/When_Using_A_Treatment_Policy_Estimand"